Objectif
Protein aggregation is a hallmark of many late onset neurodegenerative disorders including Parkinson’s Disease (PD), Alzheimer’s Disease (AD), amyotrophic lateral sclerosis (ALS), prion diseases as well as the group of polyglutamine diseases (polyQ). The aim of this proposal is to create a network of European partners bridging important basic mechanisms involved in proteinopathies, research of model diseases and treatment approaches. The “TreatPolyQ” network will focus on two main representatives of the polyQ diseases: Huntington’s disease as the most common polyQ disease as well as spinocerebellar ataxia type 3 (SCA3) as the most frequent autosomal-dominantly inherited ataxia. Patients suffer from a multitude of neurological symptoms including movement abnormalities with late onset and in a progressive manner. Up to now, no treatment or cure is available. The network will be consisting of a rare combination of experts from basic and translational research, including a Nobel prize laureate, four industrial partners (two medium, and two small companies, all incorporated as full participants) and academic leaders of the field. The network not only focuses on one special aspect of a disease but spans several important disease-associated mechanism as well as promising treatment strategies for HD and SCA3 (protein transport, protein folding, protein degradation via both the ubiquitin-proteasome system and autophagy), likely to be important across a range of neurodegenerative diseases. In order to implement these research projects, extensive collaborations and temporarily personnel secondments of the involved researchers will take place, enhancing interdisciplinary transfer of knowledge. Beyond the personalized local training plan for each employed researcher within the Network, there will be 4 structured courses covering aspects ranging from structural biology to protein degradation to model organisms and drug development, including soft skill training.
Champ scientifique
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsprotein folding
- medical and health sciencesbasic medicineneurologyparkinson
- medical and health sciencesbasic medicineneurologyamyotrophic lateral sclerosis
Appel à propositions
FP7-PEOPLE-2010-ITN
Voir d’autres projets de cet appel
Régime de financement
MC-ITN - Networks for Initial Training (ITN)Coordinateur
72074 Tuebingen
Allemagne
Voir sur la carte
Participants (15)
80539 Munchen
Voir sur la carte
75231 Paris
Voir sur la carte
Participation terminée
2100 COPENHAGEN
Voir sur la carte
17177 Stockholm
Voir sur la carte
75794 Paris
Voir sur la carte
32000 Haifa
Voir sur la carte
CB2 1TN Cambridge
Voir sur la carte
1015 Lausanne
Voir sur la carte
3004 517 Coimbra
Voir sur la carte
WC2R 2LS London
Voir sur la carte
53100 SIENA
Voir sur la carte
2500 Valby
Voir sur la carte
F-75205 / 13 Paris
Voir sur la carte
22100 LUND
Voir sur la carte
Participation terminée
2750 BALLERUP
Voir sur la carte